Difficulty: Medium
Average Score: 76%
Practice
In relation to the molecular mechanism of action of sympathomimetics the following is CORRECT:
Correct answer
D
Rationale
In this question, the correct answer is D) Alpha 1 receptor stimulation releases IP3 and DAG. This is correct because when alpha 1 receptors are stimulated, it leads to the activation of phospholipase C, which in turn cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 then triggers the release of calcium from intracellular stores, leading to various cellular responses.
Now, let's analyze why the other options are incorrect:
A) Beta receptor stimulation does not increase c-GMP. Beta receptors primarily act through the cyclic adenosine monophosphate (cAMP) pathway.
B) Alpha 2 receptor stimulation does not stimulate adenyl cyclase. Instead, it inhibits adenyl cyclase activity leading to a decrease in cAMP levels.
C) Alpha 2 receptor stimulation does not increase cAMP. As mentioned earlier, alpha 2 receptors inhibit adenyl cyclase activity, leading to a decrease in cAMP levels.
Educational Context:
Understanding the molecular mechanisms of action of sympathomimetics is crucial in pharmacology and clinical practice. This knowledge helps healthcare professionals comprehend how these drugs affect various receptors in the central and peripheral nervous systems, leading to specific physiological responses. Being able to differentiate between different receptor responses is vital for selecting appropriate drug therapies and predicting potential side effects or interactions.
Now, let's analyze why the other options are incorrect:
A) Beta receptor stimulation does not increase c-GMP. Beta receptors primarily act through the cyclic adenosine monophosphate (cAMP) pathway.
B) Alpha 2 receptor stimulation does not stimulate adenyl cyclase. Instead, it inhibits adenyl cyclase activity leading to a decrease in cAMP levels.
C) Alpha 2 receptor stimulation does not increase cAMP. As mentioned earlier, alpha 2 receptors inhibit adenyl cyclase activity, leading to a decrease in cAMP levels.
Educational Context:
Understanding the molecular mechanisms of action of sympathomimetics is crucial in pharmacology and clinical practice. This knowledge helps healthcare professionals comprehend how these drugs affect various receptors in the central and peripheral nervous systems, leading to specific physiological responses. Being able to differentiate between different receptor responses is vital for selecting appropriate drug therapies and predicting potential side effects or interactions.